Duratocin RTS Injection
Marketer
Ferring Pharmaceuticals
Salt Composition
Carbetocin (100mcg/ml)
Overview Duratocin RTS Injection
Postpartum hemorrhage is treated with Duratocin RTS Injection, an intravenous medication administered by healthcare professionals. Delayed uterine contraction following childbirth increases the risk of excessive bleeding; this injection stimulates uterine contraction to mitigate this risk. Self-administration is strictly prohibited; the injection is given only after delivery. Prior to administration, inform your physician of any existing medical conditions. Common side effects include nausea, abdominal pain, pruritus, flushing, hypotension, cephalalgia, and tremors. Report any concerning or worsening side effects, or the onset of new symptoms during treatment, to your doctor. Contraindications include allergy to any constituent, renal or hepatic impairment, cardiac disease, epilepsy, migraine history, asthma, or pre-eclampsia. Its use is contraindicated during pregnancy.
Uses of Duratocin RTS Injection
Minimizing Hemorrhage After Childbirth
Major Benefits of Duratocin RTS Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Duratocin RTS Injection:
- Nausea
- Stomach pain
- Itching
- Headache
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hypotension (low blood pressure)
- Tremors
- Vomiting
- Back pain
- Chest pain
- Metallic taste
- Anemia (low number of red blood cells)
- Breathlessness
- Chills
- Generalized pain
How to use Duratocin RTS Injection:
Administering this medication will be handled by your healthcare provider; please do not attempt self-medication.
How Duratocin RTS Injection works:
Duratocin RTS Injection is an oxytocin receptor agonist, a type of medication that mimics the action of oxytocin. Oxytocin's natural role is to stimulate uterine muscle contractions during labor. The injection works by activating oxytocin receptors in the uterine smooth muscle, thereby promoting contractions. These rhythmic contractions facilitate delivery and minimize postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Duratocin RTS Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Duratocin RTS Injection during pregnancy carries substantial risk. Pregnant individuals should consult their physician; research in animal and human studies reveals considerable potential harm to the fetus.
Breast feedingSAFE IF PRESCRIBED
Lactation is compatible with the use of Duratocin RTS Injection. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Duratocin RTS Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyUNSAFE
The use of Duratocin RTS Injection is likely contraindicated in individuals with renal impairment and should be omitted. Physician consultation is advised.
LiverUNSAFE
The use of Duratocin RTS Injection in individuals with hepatic impairment is potentially hazardous and should be avoided. Seek medical advice before administering.
What if you forget to take Duratocin RTS Injection :
Should you forget a scheduled Duratocin RTS Injection, seek advice from your physician.
Facts to Know About Duratocin RTS Injection
| Label | Value |
|---|---|
| Chemical Classification | Carboxylic Acid Derivatives |
| Developing Habits | No. |
| Type of Therapy | Obstetrics and Gynecology |
| Action Class | Oxytocin Receptor Blocker |



